AMD's 8.2% Jump Has Two Engines — Only One of Them Is AMD's to Control
E.ON Weighs Turning Shuttered Nuclear Sites Into Data Centres as Capex Resolve Weighs on Shares
Healthineers Wins Higher Targets but Not Upgrades as Diagnostics Drags on the Turnaround
Infineon Wins the Data-Centre Power Mandate, Then Asks Investors to Trust the Cash
Almonty's Sangdong Ramp-Up Stumbles as a $67 Million Canadian Dispute Cuts Across the Story
TUI Balances Expansion Against Cruise Disruption Ahead of December 9 Annual Results
Deutsche Bank's Digital Push Now Rests on Two Tests: Paying Clients and 20,000 Trained Staff
Nokia's New Zealand Deployment Gives Its AI Order Book a Proving Ground
Munich Re Hands Aon the Pricing Pen in Southeast Asia While JPMorgan Signs Off on the Rally
Thyssenkrupp's Two Clocks: Nucera's Indian Startup Versus Duisburg's 2029 Green-Steel Date
Renk's Order Book Swells to €7.6 Billion, but Boxer Delays Put Revenue Timing in the Spotlight
Nvidia's Board Brings In a Former U.S. Attorney as Wall Street Waits for the November 17 Verdict
Xiaomi Sinks With Hong Kong Tech Peers as Buyback and Daiwa Upgrade Fail to Halt Slide
Andritz Lifts Revenue 9.2% as Order Intake Stays Above €2 Billion for Eighth Straight Quarter
Berkshire's 19-Point Edge Over the S&P Is Really a Bet on How Long the AI Retreat Lasts
Biomatter Raises $18M Series A to Scale Its AI-Powered Enzyme Design for Global Industry Leaders
Alphabet Rides AI Rebound as Arete Trims Target and Asian Bond Debut Takes Shape
Steyr Motors Investors Face a Two-Track Bet: a €39 Cash Exit or a 2027 Order Wave
BASF's Louisiana MDI Start-Up Meets a Jefferies Downgrade
VanEck Rare Earth ETF Recovers From 52-Week Low as MP Materials Upgrade Offsets Cautious Export Data
Vincorion Slips as Weak Orders Overshadow JPMorgan's Bullish Call
BioNTech's $205 Million Voucher Is Only as Good as the Filing Behind It
SanDisk Surges as CoreWeave's Raised Guidance Rekindles AI Infrastructure Bets
Rocket Lab's $3.57 Billion Backlog Sets a Delivery Test for 2027
BYD Unveils Yangwang Altior in Abu Dhabi as BlackRock Trims Stake and Q3 Profit Trails Forecasts
Vonovia's Buy Case Now Rests on a 22.70 Euro Question Mark
Voestalpine's €290 Million Half-Year Profit Meets a €1.4 Billion Debt Test
Blackstone Backs Pfizer's Obesity Bet as Analysts Turn More Bullish
Allianz's Raised Guidance Faces a November 12 Reckoning as Claims Costs Creep Higher
Moderna Bets on Manufacturing Muscle as Vaccine Data and Canadian Approvals Broaden the Story
CSG's €18 Billion Backlog Meets a Cash Drain and a Thinner Margin
Mercedes-Benz Tests Investor Patience as Buyback, Cost Talks and China Slump Collide
AstraZeneca Cloud Shift and a Walldorf Concept Store Put SAP's AI Ambitions to the Test